In this study, in vitro experiments showed 212Pb-daratumumab–specific effects on proliferation of cells with high CD38 expression, as is consistent with previous observations by Teiluf et al. on different MM cell lines, including RPMI8226. Here, CD38 is linked to Miyoshi myopathy.